Skip to content

VEIN Health - CVD Prevalence and Characteristics

VEIN Health Chronic Venous Disease at Primary and Specialized Healthcare Level -Update on Prevalence and Characteristics

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04901845
Enrollment
10000
Registered
2021-05-26
Start date
2021-05-31
Completion date
2021-09-30
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Venous Disease

Keywords

Chronic Venous Disease, Prevalence, Characteristics, Management tactics evaluation, Risk-factors, Distribution of CEAP stages

Brief summary

Epidemiology Study to learn prevalence and characteristics of CVD at Primary and Specialized healthcare level

Detailed description

Cross sectional study that will evaluate prevalence, characteristics, diagnostic and treatment status of the patients with Chronic Venous Disease at primary or specialized healthcare level during 2 week period. No interventions are made. Information on patient demographic, physical, clinical parameters, medical history data and procedures performed during visit in routine daily practice of physicians is registered and analyzed.

Interventions

Study is provided in the usual daily practice of the physicians without interventions made in their practice

Sponsors

Chapidze Emergency Cardiology Center
CollaboratorUNKNOWN
Bokhua Memorial Cardiovascular Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age above 18 years * Patient consented to participate

Exclusion criteria

* Patient applying due to emergency situation

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of CVD2 weeksPercent of CVD symptomatic patients among patients applying to consultation for any reason
Distribution of CEAP stages2 weeksPercent of CVD patients with various CEAP stages
Prevalence of risk-factors associated with CVD2 weeksFrequency of risk-factors associated with CVD
Management tactics2 weeksTactics chosen by physicians to manage CVD

Contacts

Primary ContactMamuka Bokuchava, MD, PhD
bmamuka@hotmail.com+995577434075
Backup ContactManana Silagava, MD
mano.silagava@yahoo.com+995599091728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026